NuProtein Capital, LLC has officially filed a new offering under the SEC rules, aiming to raise $12.5 million. This significant move is important as it marks the company's entry into the investment fund sector, indicating potential growth and interest in equity-type securities.

Founded in 2026, NuProtein Capital operates as a limited liability company based in St. Charles, Illinois. The company is incorporated in South Dakota and has recently filed two offerings, including this latest one dated November 4, 2026.

The filing states that the offering is not an amendment and that the date of the first sale is yet to occur. The total offering amount matches the total amount sold, indicating that the company has successfully secured the full amount it aimed to raise. The filing also notes that there are no sales commissions or finder’s fees associated with this offering.

According to the filing, Ted A. Meyers serves as the executive officer and manager of the issuer. The company currently does not have any non-accredited investors and has not disclosed its aggregate net asset value.

This new offering may affect potential investors looking to enter the pooled investment fund market. However, the filing does not specify what the next steps will be regarding the offering or any further filings.